BioVie to Present Rationale for use of NE3107 for the Treatment of Alzheimer's Disease at 2021 Alzheimer's Association International Conference

Got To Article
BioVie Inc., a clinical-stage company developing innovative drug therapies for the treatment of liver disease, neurodegenerative disease and certain cancers, announced today that Poster 55458 entitled “ Rationale for an Anti-inflammatory Insulin Sensitizer in a Phase 3 Alzheimer’s Disease Trial” by Christopher L Reading,
0 comments

California sues Activision Blizzard, alleging culture of sexual harassment

Got To Article
By Alexandra Meeks, CNN Business California’s Department of Fair Employment and Housing filed a civil lawsuit Tuesday against one of America’s largest video game developers Activision Blizzard, alleging multiple female employees were subjected to gender discrimination,
0 comments